Monocyte Activation Test Market Exploring Future Growth 2019-2030 and Key Players - Merck, Thermo Fisher Scientific, Becton
Market Industry Reports (MIR) has published a new report titled "Monocyte Activation Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030." The global Monocyte Activation Test market was valued at over US$ 6.5 Mn. in 2018 and is anticipated to grow at a CAGR of 12.5% from 2019 to 2030.
Monocyte activation test based on the reaction of human monocytes, now allows predicting the human response to all pyrogens (i.e. endotoxin and non-endotoxin) in vitro. The MAT can be used as alternative to animal-based pyrogen testing. The MAT is used to detect or quantify substances that activate human monocytes or monocyte cells to release endogenous mediators which have a role in the human fever response. The MAT offers significant advantages over animal-based pyrogen testing: based on the human fever response, it provides a more relevant prediction of pyrogenic activity than the rabbit pyrogen test (RPT), it can detect endotoxin and non-endotoxin pyrogens and is applicable to a greater variety of products than the RPT; moreover, it is more accurate as well as more cost and time-effective than various other pyrogen tests.
Major Key Players of the Monocyte Activation Test Market are:Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.
Read More @ https://www.openpr.com/news/2011589/monocyte-activation-test-market-exploring-future-growth
Monocyte activation test based on the reaction of human monocytes, now allows predicting the human response to all pyrogens (i.e. endotoxin and non-endotoxin) in vitro. The MAT can be used as alternative to animal-based pyrogen testing. The MAT is used to detect or quantify substances that activate human monocytes or monocyte cells to release endogenous mediators which have a role in the human fever response. The MAT offers significant advantages over animal-based pyrogen testing: based on the human fever response, it provides a more relevant prediction of pyrogenic activity than the rabbit pyrogen test (RPT), it can detect endotoxin and non-endotoxin pyrogens and is applicable to a greater variety of products than the RPT; moreover, it is more accurate as well as more cost and time-effective than various other pyrogen tests.
Major Key Players of the Monocyte Activation Test Market are:Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.
Read More @ https://www.openpr.com/news/2011589/monocyte-activation-test-market-exploring-future-growth
Comments
Post a Comment